Drug Topics
JUNE 27, 2023
Barriers that continue to exist include the challenges of recruiting exceptional pharmacists and the changing landscape of therapies for dermatologic conditions.
STAT
JUNE 27, 2023
WASHINGTON — Grail is aggressively lobbying to get Medicare to pay for its cancer-screening test Galleri — but experts tell STAT that the company has a far more complicated path to that end than the makers of most medicines or medical devices. Grail’s controversial blood test Galleri screens for multiple cancers. The Food and Drug Administration has not yet approved it, so Medicare hasn’t had to make a decision on whether to cover it or not.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JUNE 27, 2023
Nearly two-thirds of individuals with T2D eventually develop atherosclerotic cardiovascular disease in the United States.
PharmaVoice
JUNE 27, 2023
Intercept Pharmaceuticals has stepped out of the race to the first U.S. approved treatment for the complicated liver disease NASH, leaving room for other pharmas to get their foot in the door.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
JUNE 27, 2023
Continuous glucose monitor and insulin pump use improved HbA1c.
Pharmacy Times
JUNE 27, 2023
Race, ethnicity, years after diagnosis and mental and physical stress are among factors associated with unmet supportive care needs and a higher risk of hospitalization among patients with cancer.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
JUNE 27, 2023
The findings suggest that the research conducted will be useful in enhancing the development of the HIV vaccine and can also be used to improve other viral pathogens.
Drug Topics
JUNE 27, 2023
The most frequently prescribed weight loss medication was semaglutide (Ozempic), followed by liraglutide (Saxenda), and dulaglutide (Trulicity).
Pharmacy Times
JUNE 27, 2023
The NCPA Convention will be held from October 14, 2023 through October 17, 2023, in Orlando, Florida.
Fierce Healthcare
JUNE 27, 2023
Microsoft and Nuance Communications are building on their long-standing partnerships with Epic to broaden the availability of generative AI tools for medical note-taking. | Microsoft-owned Nuance Communications is building on its long-standing partnership with Epic to broaden the availability of generative AI tools for medical note-taking.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
JUNE 27, 2023
WASHINGTON — Hundreds of activists rallied today outside of the headquarters of the country’s largest health insurance lobbying group to protest against restrictions to coverage in private Medicare plans. The protesters were crammed into an already busy part of the city. A 10-minute walk from the Capitol building and a block off the National Mall, the headquarters for America’s Health Insurance Plans is located in a part of Washington that is crowded with tourists during the
Fierce Pharma
JUNE 27, 2023
AbbVie recently filed a patent infring | AbbVie recently filed a patent infringement lawsuit against BeiGene over their blockbuster BTK franchises. Although the litigation was launched right after a patent’s issuance, AbbVie may actually have a case here, according to one expert.
Fierce Healthcare
JUNE 27, 2023
Medicare Advantage (MA) beneficiaries given home-delivered meals in the four weeks after being discharged from a hospital were not only less likely to be readmitted within 30 days, they were also l | Kaiser Permanente Southern California found that a meal delivery program for Medicare Ad-vantage beneficiaries cut mortality rates, and improved outcomes overall, according to a study in JAMA Health Forum.
Fierce Pharma
JUNE 27, 2023
This has been a second straight year of regulatory struggles in the United States for UCB with one of the those issues revolving around the FDA needing additional time to
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
European Pharmaceutical Review
JUNE 27, 2023
AC Immune SA has received Fast Track designation from the US Food and Drug Administration (FDA) for its anti-amyloid beta (Abeta) active immunotherapy vaccine candidate for Alzheimer’s disease. This follows FDA clearance of the Investigational New Drug (IND) application, enabling expansion to the US of the ongoing Phase Ib/II ABATE study of ACI-24.060 in Alzheimer’s patients and individuals with Down’s syndrome.
STAT
JUNE 27, 2023
A year after two major drugmakers sued a wholesaler for its alleged role in distributing counterfeit HIV pills, the U.S. Food and Drug Administration warned the wholesaler for failing to ensure that “suspect” medicines did not enter the marketplace. In a June 8 letter, the agency rebuked Safe Chain Solutions for violating a federal law designed to bolster the integrity of the pharmaceutical supply chain.
European Pharmaceutical Review
JUNE 27, 2023
Lonza and Vertex Pharmaceuticals Incorporated have agreed to collaborate to support the manufacture of Vertex’s Type 1 diabetes cell therapy portfolio. The companies will partner in the process development and manufacturing scale-up at a new, large-scale facility in Portsmouth, New Hampshire, US. Operated by Lonza, the 130,000 square foot facility is anticipated to create up to 300 new jobs at peak capacity.
STAT
JUNE 27, 2023
Sometimes, an apple a day really is just what the doctor ordered. And for the past several years, organizations like About Fresh , the Boston-based nonprofit where I work, have been developing tools to make such produce prescriptions possible for those who can’t afford the fresh fruits and vegetables they need. Since January 2021, we have enrolled more than 4,101 Medicaid members in our Fresh Connect produce prescription program, and to date they have spent nearly $2.8 million on the fres
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Drug Store News
JUNE 27, 2023
By the end of 2023, Walmart will have more than 80 Specialty Pharmacies of the Community locations across 10 states.
STAT
JUNE 27, 2023
Finding a new medicine is never easy. But developing treatments for patients with rare diseases — conditions that afflict fewer than 200,000 people in the United States — is particularly challenging. When there are only a few thousand or even a few hundred people living with a particular condition, finding enough patients for clinical trials can take years.
pharmaphorum
JUNE 27, 2023
AI could provide breakthrough for early diagnosis of rare diseases Mike.
STAT
JUNE 27, 2023
SAN DIEGO — It was Novo Nordisk’s Ozempic and Wegovy that set off a new era in obesity medicine, delivering unprecedented levels of weight loss and working its way into popular culture, inescapable ads, and hundreds of thousands of medicine cabinets. But Eli Lilly has been following close behind with new treatments, and after dropping result after result from successful trials at the American Diabetes Association conference here this past weekend, the Indianapolis-based drugmaker l
Pharmaceutical Technology
JUNE 27, 2023
Vertex and Lonza have entered a partnership to establish a facility in Portsmouth, US, to manufacture cell therapies for type 1 diabetes.
STAT
JUNE 27, 2023
The makers of minimally invasive surgical devices seemed poised to capture a wide swath of the obesity treatment market. Patients needed an option that lay between the two treatment extremes: cutting open the abdomen to perform permanent bariatric surgery, or changing your diet or exercise routine. Then, a new class of weight loss medications that successfully mimic the feeling of fullness hit the market, and the landscape changed.
Drug Store News
JUNE 27, 2023
Eden Drug was the recipient of Health Mart's Pharmacy of the Year, while Pharm406 received Health Mart's Innovation Award.
STAT
JUNE 27, 2023
Dear Readers, Today is an important day in the history of STAT: We have refreshed the look of our homepage and adjusted the teal color that has been synonymous with STAT since we launched nearly eight years ago.
pharmaphorum
JUNE 27, 2023
NICE not convinced yet by Mounjaro for diabetes Phil.
STAT
JUNE 27, 2023
Early this spring, dozens of volunteers fielding requests from people struggling with eating disorders — many of whom call amid mental health crises — received surprising and abrupt news: Their service at the National Eating Disorders Association would end within weeks. In their place, the nonprofit would offer an AI chatbot called Tessa.
pharmaphorum
JUNE 27, 2023
FDA fast-tracks GSK’s gonorrhoea vaccine Phil.
Pharmaceutical Technology
JUNE 27, 2023
UCB's Rystiggo has been granted FDA approval to treat myasthenia gravis in anti-AchR or anti-MuSK antibody-positive adults.
pharmaphorum
JUNE 27, 2023
UCB stakes claim to gMG market as FDA clears Rystiggo Phil.
STAT
JUNE 27, 2023
Top of the morning to you. The middle of the week is upon us and, since you made it this far, why not forge ahead? After all, there is always light at the end of the proverbial tunnel. You never know what you may accomplish. So please join us as we celebrate this notion with a cup or three of delicious stimulation. Our choice today is … maple bourbon.
Drug Store News
JUNE 27, 2023
Through the challenge, a winner will get the chance to win a block party honoring their hometown.
Expert insights. Personalized for you.
247 
Let's personalize your content